Understanding Chemotherapeutic Drug Targets
Understanding Chemotherapeutic Drug Targets
Dr. Nozomi Ando conducts research on a protein that is essential for DNA synthesis, repair and replication. She explains how this protein is in equilibrium between an active and an inactive form, and how discovering strategies to lock the protein in the inactive ...
Imaging Viruses with Nanoscale MRI
Imaging Viruses with Nanoscale MRI
Ben Ofori-Okai discusses the concept of orbital degeneracy (two orbitals with the same energy) in relation to his research on nanoscale MRI (magnetic resonance imaging)
Stopping a leak the way blood does
Stopping a leak the way blood does
Harnessing the principle that allows blood to clot, MIT researchers are working on new synthetic materials to plug holes.
Bridge Project Workshop, May 24 2012
Bridge Project Workshop, May 24 2012
Read more about the Bridge Project: http://ki.mit.edu/approach/partnerships/bridge
Protein Methyltransferase Inhibitors as Personalized Cancer ...
Protein Methyltransferase Inhibitors as Personalized Cancer Therapeutics
The Koch Institute: Summer Symposium 2012Epigenetics, Plasticity, and CancerThe 2012 Symposium, on “Epigenetics, Plasticity, and Cancer” is the 11th Annual Oncology Research Symposium and was held on Thursday, June 14, 2012. Victoria RichonVice President of ...
The Koch Institute: SOLUTIONS with/in/sight - June 7, 2012
The Koch Institute: SOLUTIONS with/in/sight - June 7, 2012
This evening event featured insights from three experts from the field of cancer immunotherapy, which seeks to harness the power of the immune system in the fight against cancer. Speakers were Glenn Dranoff, Co-Leader of the Cancer Vaccine Center at Dana-Farber Cancer ...
UROP profile: Kamena Kostova
UROP profile: Kamena Kostova
An MIT undergraduate shares her experience doing cancer research at the Koch Institute for Integrative Cancer Research, through MIT's Undergraduate Research Opportunities Program.
Stephen Quake, $500K Lemelson-MIT Prize winner
Dr. Stephen Quake - 2012 $500,000 Lemelson-MIT Prize Winner
Profile of Dr. Stephen Quake, winner of the 2012 $500,000 Lemelson-MIT Prize for his revolutionary work in drug discovery, genome analysis and personalized medicine.
Introduction to Allopathy: The unique philosophy of ...
Introduction to Allopathy: The unique philosophy of non-alternative ...
Allopathic medicine is taught by the medical schools that award M.D. degrees. At its base, is the philosophy that medical therapy should be based on science. In this moderated discussion, we'll explore both the strengths and quirks of conventional medicine ...